Dr. Scholl's

Dr. Scholl's is an American foot-care brand founded in Chicago in 1906 by the podiatrist William Mathias Scholl [6]. It is best known for insoles, orthotic inserts and over-the-counter treatments for common foot complaints, and has built its identity around a single idea its founder repeated for decades: that the condition of the feet shapes how the whole body feels.

The brand remains active and is sold in more than 50 countries. Its ownership history is unusually tangled — for several decades the North American business and the international business were held by different companies and traded under slightly different names — but both sides were reunited under one owner in 2021 [7].

William Mathias Scholl was born on 22 June 1882 in La Porte, Indiana, one of thirteen children raised on a family farm. According to the company, his grandfather was a German shoemaker, an early influence on his interest in footwear. At sixteen he moved to Chicago to apprentice at a shoe shop, where he was struck by how much foot pain he saw among city residents. He took night classes and earned a medical degree from Loyola University Chicago, and in 1904, while still a student, he invented and patented his first arch support. He founded the company two years later, in 1906 [2].

Scholl built the business around a blunt slogan that became its guiding philosophy: "When your feet hurt, you hurt all over" [2]. Over his lifetime he was credited with bringing more than 1,000 foot-care products to market, and he expanded overseas with his brother Frank. In 1947 he established the Dr. Scholl Foundation for charitable work, later donating most of his estate to it. He died in 1968.

The company grew from a single arch support into a broad foot-care range over the first half of the twentieth century. In 1971 it was named to the Fortune 500 and went public in the same year [6].

A separate strand of the brand's history runs through fashion rather than podiatry. In 1961 Dr. Scholl's introduced a wooden "exercise sandal" — a clog with a raised toe grip designed to engage the foot and leg muscles while walking. After early success in Germany, the company marketed it to "swingin' London" and brought it to the United States in 1968; by 1972 it had sold a million pairs [8]. The sandal became a recognisable feature of 1970s and 1980s style and has resurfaced in periodic revivals. Today that footwear is a separately licensed line distinct from the foot-care products the brand is otherwise built on.

The corporate history splits into two parallel timelines. Schering-Plough acquired the Dr. Scholl's brand in 1979 [6]. In 1984 it sold the global, non–North-American rights to European Home Products, later SSL International — the moment the business divided into a US "Dr. Scholl's" and an international "Scholl" [6].

From there the two halves passed through different hands. Merck & Co. took on the North American brand in 2009 through its purchase of Schering-Plough, and Bayer acquired it in 2014 via Merck's consumer-health unit. On the international side, Reckitt Benckiser bought the Scholl brand from SSL International in 2010.

The reunification came in two steps. In 2019 Bayer sold the North American Dr. Scholl's to the private-equity firm Yellow Wood Partners for $585 million; Yellow Wood formed Scholl's Wellness Company to hold it [6]. Then in June 2021 Reckitt sold the international Scholl business to the same firm, bringing both sides under one owner for the first time in more than 30 years [7]. That deal also included the Amopé, Krack and Eulactol foot-care brands. The combined company was reported to generate over $700 million in annual retail sales across more than 50 countries [7]. Because of the historic split, the brand still trades as "Scholl" in much of Europe and "Dr. Scholl's" in the Americas, though both now sit under Scholl's Wellness Company.

The brand positions itself as a foot-care specialist working "from the ground up." Its stated purpose, in the company's words, is to "eliminate fatigue, discomfort and pain at the source, so you can keep moving and enjoy a more active, healthier life." Dr. Scholl's frames this as a continuation of its founder's mission, which it describes as "scientifically supporting the feet to improve mobility." On its own site the company calls itself "the most trusted brand in foot care" and says the name has been "synonymous with foot care for more than 115 years."

The current range covers three broad areas: insoles and inserts, over-the-counter treatments, and foot skincare such as lotions, creams, balms, masks and files. Two proprietary technologies anchor the line. Custom FiT is a fitting system, offered through in-store kiosks and an online assessment, that recommends an insert and is sold in three-quarter-length orthotic and full-length comfort versions. Massaging Gel is a cushioning technology, used in the brand's work insoles, that the company describes as absorbing shock from hard surfaces to reduce muscle fatigue and joint stress.

On the treatment side, Dr. Scholl's markets products for conditions including corns, calluses, warts, bunions, ingrown toenails, athlete's foot and foot odour. The company describes one of these — a skin-tag remover — as the first over-the-counter, FDA-cleared product of its kind [1]. The lineage of these products traces back to the founder's 1904 patented arch support, the brand's first innovation.

Dr. Scholl's has built recent marketing around athlete and expert partnerships. The brand has worked with the three-time Olympic gold-medal gymnast Gabby Douglas and the nine-time Olympic track-and-field medallist Allyson Felix, the latter to launch a line of running insoles. It has also named the board-certified foot surgeon Dr. Brad Schaeffer as a brand ambassador and paid consultant.

Dr. Scholl's is an active, globally distributed brand. It maintains a current e-commerce site, ongoing product launches and athlete partnerships, and is owned by Scholl's Wellness Company under Yellow Wood Partners. The North American "Dr. Scholl's" and international "Scholl" brands, long held separately, have shared a single owner since 2021 [7].